12/21
01:08 am
mbx
High
Report
12/19
10:04 am
mbx
MBX Biosciences (NASDAQ:MBX) was given a new $50.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) was given a new $50.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
12/15
08:00 am
mbx
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
Medium
Report
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
12/13
01:10 am
mbx
MBX Biosciences (NASDAQ:MBX) was downgraded by analysts at
Wall Street Ze
Medium
Report
MBX Biosciences (NASDAQ:MBX) was downgraded by analysts at
Wall Street Ze
12/10
01:03 pm
mbx
MBX Biosciences: Testing 2026 May Deliver Another Year Of Share Price Gains [Seeking Alpha]
Low
Report
MBX Biosciences: Testing 2026 May Deliver Another Year Of Share Price Gains [Seeking Alpha]
12/6
05:47 am
mbx
MBX Biosciences (NASDAQ:MBX) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong sell" rating.
Low
Report
MBX Biosciences (NASDAQ:MBX) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong sell" rating.
12/4
06:27 pm
mbx
MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and MPM Exit - What's Changed [Yahoo! Finance]
Medium
Report
MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and MPM Exit - What's Changed [Yahoo! Finance]
12/4
08:04 am
mbx
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $18.00 price target on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $18.00 price target on the stock.
12/1
12:37 pm
mbx
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus [Yahoo! Finance]
Medium
Report
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus [Yahoo! Finance]
12/1
11:38 am
mbx
How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% [Yahoo! Finance]
Low
Report
How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% [Yahoo! Finance]
11/27
07:07 pm
mbx
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones [Yahoo! Finance]
Low
Report
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones [Yahoo! Finance]
11/18
08:42 am
mbx
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
Medium
Report
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
11/18
08:00 am
mbx
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
Medium
Report
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
11/10
10:04 am
mbx
MBX Biosciences (NASDAQ:MBX) had its price target lowered by analysts at Guggenheim from $84.00 to $77.00. They now have a "buy" rating on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) had its price target lowered by analysts at Guggenheim from $84.00 to $77.00. They now have a "buy" rating on the stock.
11/6
08:00 am
mbx
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Medium
Report
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
11/4
08:09 am
mbx
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
11/4
07:21 am
mbx
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
10/20
08:00 am
mbx
MBX Biosciences to Participate in November Investor Conferences
Medium
Report
MBX Biosciences to Participate in November Investor Conferences
10/15
08:12 am
mbx
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
MBX Biosciences (NASDAQ:MBX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $50.00 price target on the stock.
9/29
08:00 am
mbx
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
Low
Report
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
9/25
06:26 am
mbx
MBX Biosciences, Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial Transcript [Seeking Alpha]
High
Report
MBX Biosciences, Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial Transcript [Seeking Alpha]
9/24
09:28 pm
mbx
MBX Biosciences, Inc. - Special Call [Seeking Alpha]
High
Report
MBX Biosciences, Inc. - Special Call [Seeking Alpha]
9/24
09:15 pm
mbx
MBX Biosciences Announces Pricing of Upsized Public Offering
High
Report
MBX Biosciences Announces Pricing of Upsized Public Offering
9/24
09:54 am
mbx
MBX Biosciences (NYSE:MBX) had its price target raised by analysts at Mizuho from $38.00 to $56.00. They now have an "outperform" rating on the stock.
Medium
Report
MBX Biosciences (NYSE:MBX) had its price target raised by analysts at Mizuho from $38.00 to $56.00. They now have an "outperform" rating on the stock.
9/23
07:38 am
mbx
MBX Biosciences (MBX) Is Up 84.0% After Positive Phase 2 Results for Canvuparatide - Has The Bull Case Changed? [Yahoo! Finance]
Medium
Report
MBX Biosciences (MBX) Is Up 84.0% After Positive Phase 2 Results for Canvuparatide - Has The Bull Case Changed? [Yahoo! Finance]